Cromos Pharma的动态

查看Cromos Pharma的公司主页，图片
Cromos Pharma

7,618 位关注者

As we approach the end of the year, the integration of AI in clinical trials is revolutionizing drug development with groundbreaking innovations. From enhancing efficiency to enabling personalized treatments, these advancements are shaping the future of clinical research.? ? Key Highlights: - AI-generated digital twins streamline trials with fewer patients.? - Revolutionary AI tools accelerate heart failure screening.? - Organ-on-a-Chip combined with AI enhances drug evaluation.? - Protocol AI reduces trial setup time by 35 percent.? ? Read more: https://lnkd.in/e4QNXaJy #AI #ClinicalTrials #DigitalTwins #DrugDevelopment #Innovation #CromosPharma

AI in Clinical Trials: 8 Groundbreaking Innovations That Defined the Year

AI in Clinical Trials: 8 Groundbreaking Innovations That Defined the Year

Cromos Pharma，发布于领英

Seniz Sagol Tuysuz

Country Head- Global Clinical Project Management

2 天前

97% accuracy for heart failure screening is incredible. AI is making trial recruitment smarter and more efficient

赞
回复
Yuri Shchagin

Chief Business Development Officer at Cromos Pharma

3 天前

Digital twins are such a smart use of AI—fewer patients, faster trials. This feels like the future of medicine!

赞
回复
Serhii Yeletskyi

Associate Business Development Director at Cromos Pharma

2 天前

Organ-on-a-Chip + AI = fewer animal tests and faster drug results. Love it!

赞
回复
查看更多评论

要查看或添加评论，请登录

Cromos Pharma

7,618 位关注者